New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy

Neuropharmacology

Volumn 85, Issue , 2014, Pages 142-150

  Shaqura, Mohammed ^a   Khalefa, Baled I ^a   Shakibaei, Mehdi ^b   Zöllner, Christian ^c   Al Khrasani, Mahmoud ^d   Fürst, Susanna ^d   Schäfer, Michael ^a   Mousa, Shaaban A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Diabetes; Nerve growth factor; Neuropathic pain; Opioids; Sensory neuron; TRPV1

Indexed keywords

CAPSAICIN; GLUCOSE; INSULIN; MU OPIATE RECEPTOR; NERVE GROWTH FACTOR; VANILLOID RECEPTOR 1; GLUCOSE BLOOD LEVEL; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; GLUCOSE BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN SYNTHESIS; MALE; NOCICEPTION; NONHUMAN; PAINFUL DIABETIC NEUROPATHY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL GANGLION; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; MEMBRANE POTENTIAL; METABOLISM; NEURALGIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CAPSAICIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GANGLIA, SPINAL; MALE; MEMBRANE POTENTIALS; NERVE GROWTH FACTOR; NEURALGIA; RATS, WISTAR; RECEPTORS, OPIOID, MU; SENSORY RECEPTOR CELLS; SPINAL CORD; TRPV CATION CHANNELS;

EID: 84902294453     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.05.026     Document Type: Article

References (38)

1. N.A. Calcutt, M.C. Jorge, T.L. Yaksh, and S.R. Chaplan Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine Pain 68 1996 293 299
2. S.R. Chaplan, F.W. Bach, J.W. Pogrel, J.M. Chung, and T.L. Yaksh Quantitative assessment of tactile allodynia in the rat paw J. Neurosci. Methods 53 1994 55 63
3. S.R. Chen, and H.L. Pan Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats Anesthesiology 98 2003 217 222
4. S.R. Chen, and H.L. Pan Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats Anesthesiology 99 2003 1409 1414
5. S.R. Chen, K.L. Sweigart, J.M. Lakoski, and H.L. Pan Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats Anesthesiology 97 2002 1602 1608
6. C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip, and A. Eschalier Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics? J. Pharmacol. Exp. Ther. 285 1998 63 70
7. C. Daousi, I.A. MacFarlane, A. Woodward, T.J. Nurmikko, P.E. Bundred, and S.J. Benbow Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes Diabet. Med. 21 2004 976 982
8. W.J. Dixon Efficient analysis of experimental observations Annu. Rev. Pharmacol. Toxicol. 20 1980 441 462
9. J. Endres-Becker, P.A. Heppenstall, S.A. Mousa, D. Labuz, A. Oksche, C. Stein, M. Schäfer, and C. Zöllner Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain Mol. Pharmacol. 71 2007 12 18
10. M.S. Gold, and J.D. Levine DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro Neurosci. Lett. 212 1996 83 86
11. B. Heinke, E. Gingl, and J. Sandkühler Multiple targets of μ-opioid receptor-mediated presynaptic inhibition at primary afferent Aδ- and C-fibers J. Neurosci. 31 2011 1313 1322
12. R. Hellweg, G. Raivich, H.D. Hartung, C. Hock, and G.W. Kreutzberg Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy Exp. Neurol. 130 1994 24 30
13. S. Hong, and J.W. Wiley Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1 J. Biol. Chem. 280 2005 618 627
14. H. Kanbayashi, H. Itoh, T. Kashiwaya, K. Atoh, and I. Makino Spatial distribution of nociceptive neuropeptide and nerve growth factor depletion in experimental diabetic peripheral nervous system J. Int. Med. Res. 35 2002 512 519
15. L. Martini, and J.L. Whistler The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence Curr. Opin. Neurobiol. 17 2007 556 564
16. D.C. Molliver, J. Lindsay, K.M. Albers, and B.M. Davis Overexpression of NGF or GDNF alters transcriptional plasticity evoked by inflammation Pain 113 2005 277 284
17. S.A. Mousa, B.P. Cheppudira, M. Shaqura, O. Fischer, J. Hofmann, R. Hellweg, and M. Schäfer Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain Brain 130 2007 502 513
18. S.A. Mousa, M. Shaqura, B.I. Khalefa, C. Zöllner, L. Schaad, J. Schneider, T.S. Shippenberg, J.F. Richter, R. Hellweg, M. Shakibaei, and M. Schäfer Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy Diabetes 62 2013 1308 1319
19. A.K. Naik, S.K. Tandan, D. Kumar, and S.P. Dudhgaonkar Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats Eur. J. Pharmacol. 530 2006 59 69
20. C.K. Nielsen, F.B. Ross, S. Lotfipour, K.S. Saini, S.R. Edwards, and M.T. Smith Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain Pain 132 2007 289 300
21. M. Ohsawa, and J. Kamei Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5]enkephalin-induced antinociception in diabetic mice Eur. J. Pharmacol. 339 1997 27 31
22. R.M. Pabbidi, S.Q. Yu, S. Peng, R. Khardori, M.E. Pauza, and L.S. Premkumar Influence of TRPV1 on diabetes-induced alterations in thermal pain sensitivity Mol. Pain 1 2008 4 9
23. P. Puntambekar, J. Van Buren, M. Raisinghani, L.S. Premkumar, and V. Ramkumar Direct interaction of adenosine with the TRPV1 channel protein J. Neurosci. 24 2004 3663 3671
24. G. Scherrer, S.A. Low, X. Wang, J. Zhang, H. Yamanaka, R. Urban, C. Solorzano, B. Harper, T.S. Hnasko, R.H. Edwards, and A.I. Basbaum VGLUT2 expression in primary afferent neurons is essential for normal acute pain and injury-induced heat hypersensitivity Proc. Natl. Acad. Sci. U. S. A. 107 2010 22296 22301
25. Y. Shangguan, K.E. Hall, R.R. Neubig, and J.W. Wiley Diabetic neuropathy: inhibitory G protein dysfunction involves PKC-dependent phosphorylation of Goalpha J. Neurochem. 86 2003 1006 1014
26. M. Shaqura, B.I. Khalefa, M. Shakibaei, J. Winkler, M. Al-Khrasani, S. Fürst, S.A. Mousa, and M. Schäfer Reduced number, g protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor J. Pain 14 2013 720 730
27. M.A. Shaqura, C. Zollner, S.A. Mousa, C. Stein, and M. Schäfer Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain J. Pharmacol. Exp. Ther. 308 2004 712 718
28. V. Spahn, O. Fischer, J. Endres-Becker, M. Schäfer, C. Stein, and C. Zöllner Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner Pain 154 2013 598 608
29. T. Wang, D.C. Molliver, X. Jing, E.S. Schwartz, F.C. Yang, O.A. Samad, Q. Ma, and B.M. Davis Phenotypic switching of nonpeptidergic cutaneous sensory neurons following peripheral nerve injury PLoS One 6 2011 e28908
30. 2+ channels in rat dorsal root ganglion neurons J. Neurophysiol. 73 1995 1793 1798
31. N. Yabaluri, and F. Medzihradsky Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling Mol. Pharmacol. 52 1997 896 902
32. J. Yamamoto, T. Kawamata, Y. Niiyama, K. Omote, and A. Namiki Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain Neuroscience 151 2008 843 853
33. R.S. Yamdeu, M. Shaqura, S.A. Mousa, M. Schäfer, and J. Droese p38 Mitogen-activated protein kinase activation by nerve growth factor in primary sensory neurons upregulates μ-opioid receptors to enhance opioid responsiveness toward better pain control Anesthesiology 114 2011 150 161
34. D. Ziegler, Y.L. Pritchett, F. Wang, D. Desaiah, M.J. Robinson, J.A. Hall, and A.S. Chappell Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain Diabetes Care 30 2007 664 669
35. C. Zöllner, S.A. Mousa, O. Fischer, H.L. Rittner, M. Shaqura, A. Brack, M. Shakibaei, W. Binder, F. Urban, C. Stein, and M. Schäfer Inflammatory pain prevents the development of tolerance at peripheral opioid receptors J. Clin. Investig. 118 2008 1065 1673
36. C. Zöllner, M.A. Shaqura, C.P. Bopaiah, S.A. Mousa, C. Stein, and M. Schäfer Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons Mol. Pharmacol. 64 2003 202 210
37. J.R. Zurek, R. Nadeson, and C.S. Goodchild Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats Pain 90 2001 57 63
38. M. Zwick, D.C. Molliver, J. Lindsay, C.A. Fairbanks, T. Sengoku, K.M. Albers, and B.M. Davis Transgenic mice possessing increased numbers of nociceptors do not exhibit increased behavioral sensitivity in models of inflammatory and neuropathic pain Pain 106 2003 491 500